Oberweis Asset Management Inc Ani Pharmaceuticals Inc Transaction History
Oberweis Asset Management Inc
- $2.13 Billion
- Q2 2025
A detailed history of Oberweis Asset Management Inc transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Oberweis Asset Management Inc holds 138,900 shares of ANIP stock, worth $12.9 Million. This represents 0.43% of its overall portfolio holdings.
Number of Shares
138,900
Previous 65,600
111.74%
Holding current value
$12.9 Million
Previous $4.39 Million
106.4%
% of portfolio
0.43%
Previous 0.23%
Shares
4 transactions
Others Institutions Holding ANIP
# of Institutions
251Shares Held
19.8MCall Options Held
19.9KPut Options Held
12.8K-
Black Rock Inc. New York, NY2.66MShares$246 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.28MShares$118 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1MShares$92.9 Million0.03% of portfolio
-
Global Alpha Capital Management Ltd.862KShares$79.8 Million3.45% of portfolio
-
State Street Corp Boston, MA716KShares$66.3 Million0.0% of portfolio
About ANI PHARMACEUTICALS INC
- Ticker ANIP
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 17,426,000
- Market Cap $1.61B
- Description
- ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...